Research and Development

Showing 15 posts of 9600 posts found.

Aveo to cut workforce after FDA knock-back

June 6, 2013 Research and Development, Sales and Marketing Aveo, FDA, cuts, tivozanib

Aveo will make major jobs cuts this year after news that a kidney cancer licence for its oncology drug tivozanib …

Novartis drug shows cancer promise

June 5, 2013 Research and Development, Sales and Marketing ASCO, Cancer, Novartis

A Novartis drug which has been given breakthrough therapy designation by the FDA has demonstrated early promise in patients with …
GSK image

GSK licences RA drug

June 5, 2013 Research and Development, Sales and Marketing GSK, RA, morphosys

GlaxoSmithKline is gambling millions of euros on an investigational drug in a bid to get an edge in the fight …
astrazeneca image

AstraZeneca abandons late-stage RA drug

June 5, 2013 Research and Development, Sales and Marketing AstraZeneca, RA, Rigel

AstraZeneca is to exit development of a new rheumatoid arthritis drug, after Phase III trials produced disappointing results.The Anglo-Swedish firm …

Sanofi admits $285m failure

June 4, 2013 Research and Development, Sales and Marketing Sanofi, its benzamide iniparib, otamixaban

Sanofi has consigned two investigational drugs to the corporate dustbin, preferring a $285 million dent in its coffers to continuing …
Boehringer image

NSCLC lift for Boehringer

June 4, 2013 Research and Development, Sales and Marketing Boehringer, NSCLC

Boehringer’s pipeline has been boosted with the news that its investigational oral triple angiokinase inhibitor nintedanib plus chemotherapy, extends the …
brent_lang

Vocera appoints president and chief executive

June 4, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brent Lang, Vocera

Healthcare comms firm Vocera Communications has announced Brent Lang’s appointment as president and chief executive officer to the firm and …
Howe and Willetts image

UK government cautious on trial transparency

June 4, 2013 Research and Development, Sales and Marketing Goldacre, UK, alltrials, transparency

Two ministers with responsibility for life sciences in the UK struck a cautious note over clinical trial transparency at an …

Sinovac appoints chief financial officer

June 3, 2013 Manufacturing and Production, Research and Development, Sales and Marketing China, Sinovac

China-based biopharma products provider Sinovac Biotech has appointed vice president Nan Wang to be its chief financial officer. Previous CFO …
Europe image

Europe votes yes on greater trial transparency

June 3, 2013 Research and Development, Sales and Marketing Europe, Goldacre, alltrials, transparency

Europe has taken one step closer to increasing clinical trial transparency on the continent after MEPs voted yes on new …
Roche image

Lilly and Roche back US research institute

May 31, 2013 Research and Development, Sales and Marketing Roche, lilly, notre dame, research

Eli Lilly and Roche Diagnostics are among the key backers of a $360 million US life sciences research facility which …
ramani

Avillion appoints chief business officer

May 31, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Avillion

Venture capitalist firm Avillion has announced the expansion of its leadership team with the appointment of Ramani Varanasi as chief …
Goldacre image

Bad pharma, good pharma: an insider’s view

May 30, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bad pharma, Goldacre, NICE, transparancy

Most people in the pharmaceutical industry, particularly in the UK, will be well-acquainted with Ben Goldacre by now. He published his …

SCM Pharma appoints new director

May 30, 2013 Manufacturing and Production, Research and Development, Sales and Marketing SCM Pharma

UK-based contract development and manufacturing organisation SCM Pharma has strengthened its senior management team by recruiting a director. Paul Bradley …
Novartis image

Diovan trials may have been run by Novartis staff

May 29, 2013 Research and Development, Sales and Marketing Diovan, Novartis

Several post-marketing clinical trials of the blockbuster blood pressure drug Diovan may have been run by employees of the drug’s …
The Gateway to Local Adoption Series

Latest content